This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NewtekOne (NEWT) Agrees to Divest Newtek Technology to Paltalk
by Zacks Equity Research
NewtekOne (NEWT) enters an agreement to sell its wholly-owned subsidiary to Paltalk.
Is the Options Market Predicting a Spike in Citigroup (C) Stock?
by Zacks Equity Research
Investors need to pay close attention to Citigroup (C) stock based on the movements in the options market lately.
Citigroup (C) to Sell Trust Business as Part of Overhaul Plan
by Zacks Equity Research
Citigroup (C) plans to sell its trust business as part of its reorganization plan to enhance efficiency in its primary business segments.
Is Trending Stock Citigroup Inc. (C) a Buy Now?
by Zacks Equity Research
Citigroup (C) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Societe Generale (SCGLY) to Divest Operations, Boost Efficiency
by Zacks Equity Research
Societe Generale (SCGLY) plans to divest its private banking businesses in the U.K. and Switzerland, and its Madagascar subsidiary as part of its broader restructuring strategy.
U.S. Bank Stocks Fell Amid Concern of Economic Slowdown
by Riya Anand
Shares of Citigroup (C), JPMorgan (JPM), Bank of America (BAC), Wells Fargo (WFC), Goldman Sachs (GS) and other U.S. banks tumbled after a weak July jobs report.
Mitsubishi UFJ (MUFG) to Extend in APAC With New Investment
by Zacks Equity Research
Mitsubishi UFJ (MUFG) is expanding its foothold in Asia's digital financial market by investing in Globe Fintech Innovations.
Citigroup (C) Breaches Fed's Rule for Intercompany Transaction
by Zacks Equity Research
Citigroup (C) violates the Federal Reserve's Regulation W, which has led to discrepancies in its internal liquidity reporting.
Ameriprise Financial (AMP) Sues LPL Financial (LPLA) Unit
by Zacks Equity Research
Ameriprise (AMP) files a lawsuit against LPL Financial's (LPLA) arm, alleging misconduct and misuse of clients' confidential data and directing advisors to take information from their former companies.
JPMorgan (JPM) Stock Near 52-Week High: Right Time to Buy?
by Swayta Shah
With JPMorgan (JPM) trading near its 52-week high, should investors consider buying the stock now or wait for the dip? Let's try to figure that out.
Wells Fargo (WFC) Faces Lawsuit Over Employees High Drug Costs
by Zacks Equity Research
Wells Fargo (WFC) faces a lawsuit that claims it violated a federal law requiring firms to manage employee health and retirement programs properly.
Citigroup (C) Stock Rallies 27.3% YTD: What's Next for Investors?
by Riya Anand
Citigroup's (C) strength in the IB business and improving fee-based income looks favorable. However, rising expenses are a concern. Should investors buy the stock or wait for a better entry point?
JPMorgan (JPM) Launches New AI Research Analyst Chatbot
by Zacks Equity Research
JPMorgan (JPM) rolls out a new generative AI research analyst chatbot among its employees to assist in general-purpose productivity tasks. This move aligns with other leading banks' aim of AI integration.
The Zacks Analyst Blog Highlights SAP, Abbott Laboratories, Citigroup, Team and Vaso
by Zacks Equity Research
SAP, Abbott Laboratories, Citigroup, Team and Vaso are part of the Zacks top Analyst Blog.
4 Stocks That Recently Hiked Dividends in Focus
by Ritujay Ghosh
Cintas Corporation (CTAS), Citigroup Inc. (C), Community Financial System, Inc. (CBU) and Bank First Corporation (BFC) recently hiked their dividends.
Citigroup Inc. (C) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Citigroup (C) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Abbott Laboratories (ABT) and Citigroup Inc. (C), as well as two micro-cap stocks Team, Inc. (TISI) and Vaso Corporation (VASO).
Is Wells Fargo (WFC) Worth a Bet Post Q2 Earnings Beat?
by Riya Anand
Wells Fargo's (WFC) strength in fee-based income and capital adequacy seems favorable. However, the existing asset cap is a concern.
BAC Stock Near 2-Year High Post Q2 Earnings: Too Late to Invest?
by Swayta Shah
Bank of America (BAC) stock is trading near its 2-year high after releasing better-than-expected Q2 earnings. Here we assess whether it is too late to buy the shares or still have an opportunity to accumulate them.
What You Need to Know About Bank ETFs In Light of Q2 Earnings
by Sanghamitra Saha
U.S. banking earnings indicate solid investment banking performance and tepid consumer finances.
Should You Invest in Citigroup (C) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Citigroup (C). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Morgan Stanley (MS) Q2 Earnings Beat on Robust IB & Trading
by Zacks Equity Research
The resurgence of the capital markets businesses majorly supports Morgan Stanley's (MS) Q2 earnings, while the muted wealth management business acts as a spoilsport.
Dow Closes at New High as Q2 Earnings Season Heats Up
by Mark Vickery
Earnings season only picks up steam in the weeks to come.
JPMorgan, Citigroup and Wells Fargo are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, Citigroup and Wells Fargo have been highlighted in this Earnings Preview article.
Q2 Earnings Growth Expected to Reach Two-Year High
by Sheraz Mian
We see the Q2 results from the major banks as good enough - not great, but definitely not bad either. The stocks' outperformance entering this reporting cycle contributed to the market's tentative initial reaction to the results.